D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$708M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$614M |
| 3 |
Merck
MRK
|
+$521M |
| 4 |
Bank of America
BAC
|
+$492M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$646M |
| 2 |
Tesla
TSLA
|
+$607M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Broadcom
AVGO
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.84% |
| 2 | Consumer Discretionary | 9.28% |
| 3 | Healthcare | 6.84% |
| 4 | Financials | 6.63% |
| 5 | Industrials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Howard Hughes
HHH
$3.93B
| $301K | ﹤0.01% |
3,881
-28,377
| -88% | -$2M |
|
3827
PUT
Hecla Mining
HL
$10.2B
| $300K | ﹤0.01% |
+45,000
| New | +$263K |
|
3828
BlackRock Capital Allocation Term Trust
BCAT
$1.61B
| $300K | ﹤0.01% |
18,238
-9,660
| -35% | -$158K |
|
|
LAC
3829
CALL
Lithium Americas
LAC
$1.02B
| $300K | ﹤0.01% |
111,100
-104,000
| -48% | -$264K |
|
3830
Cavco Industries
CVCO
$4.46B
| $299K | ﹤0.01% |
699
| – | – |
|
3831
Liquidity Services
LQDT
$1.21B
| $298K | ﹤0.01% |
+13,086
| New | +$282K |
|
3832
United Bankshares
UBSI
$6.57B
| $297K | ﹤0.01% |
8,015
-47,655
| -86% | -$1.74M |
|
3833
Capital Group Growth ETF
CGGR
$23.7B
| $297K | ﹤0.01% |
+8,544
| New | +$283K |
|
|
SAGE
3834
PUT
DELISTED
Sage Therapeutics
SAGE
| $297K | ﹤0.01% |
41,100
-5,000
| -11% | -$45.8K |
|
3835
CALL
Vail Resorts
MTN
$5.28B
| $296K | ﹤0.01% |
+1,700
| New | +$304K |
|
3836
Ameren
AEE
$31B
| $295K | ﹤0.01% |
3,374
-53,907
| -94% | -$4.32M |
|
3837
Willis Towers Watson
WTW
$28.6B
| $295K | ﹤0.01% |
1,000
-100
| -9% | -$28K |
|
3838
Global X Genomics & Biotechnology ETF
GNOM
$78.6M
| $294K | ﹤0.01% |
6,526
+1,464
| +29% | +$65.4K |
|
3839
ONE Gas
OGS
$5.02B
| $294K | ﹤0.01% |
3,945
-400
| -9% | -$27.5K |
|
|
BCPC
3840
Balchem Corp
BCPC
$5.29B
| $293K | ﹤0.01% |
1,667
| – | – |
|
3841
Douglas Dynamics
PLOW
$1.04B
| $292K | ﹤0.01% |
10,575
-84,370
| -89% | -$2.22M |
|
3842
iQIYI
IQ
$1.19B
| $291K | ﹤0.01% |
+101,600
| New | +$295K |
|
|
LOGC
3843
CALL
DELISTED
ContextLogic
LOGC
| $290K | ﹤0.01% |
53,300
| – | – |
|
3844
Outset Medical
OM
$80.1M
| $290K | ﹤0.01% |
28,576
-56,567
| -66% | -$1.68M |
|
3845
State Street SPDR S&P Pharmaceuticals ETF
XPH
$480M
| $290K | ﹤0.01% |
+6,538
| New | +$280K |
|
3846
PUT
Mohawk Industries
MHK
$7.05B
| $289K | ﹤0.01% |
1,800
| – | – |
|
3847
Monarch Casino & Resort
MCRI
$2.18B
| $289K | ﹤0.01% |
3,645
-6,145
| -63% | -$451K |
|
3848
John B. Sanfilippo & Son
JBSS
$978M
| $289K | ﹤0.01% |
3,060
| – | – |
|
|
FLIC
3849
DELISTED
First of Long Island Corp
FLIC
| $289K | ﹤0.01% |
22,423
-29,163
| -57% | -$355K |
|
3850
CALL
Compass Minerals
CMP
$1.25B
| $288K | ﹤0.01% |
24,000
+9,100
| +61% | +$96.4K |
|
Similar funds
D.E. Shaw & Co's Q3 2024 Portfolio in Review
As of Q3 2024, D.E. Shaw & Co held 5,052 positions worth $116B, up 8.9% from $107B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2024 filing shows 599 new, 1,568 increased, 1,742 reduced and 558 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M. The largest sale was Adobe, an estimated $646M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M.
- D.E. Shaw & Co added most to NVIDIA in Q3 2024, an estimated $708M increase.
- D.E. Shaw & Co's biggest Q3 2024 reduction was Adobe, cutting an estimated $646M.
- D.E. Shaw & Co fully exited WestRock Company in Q3 2024, selling an estimated $148M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $116B portfolio in Q3 2024.
- D.E. Shaw & Co opened 599 new positions and closed 558 in Q3 2024.
- D.E. Shaw & Co's portfolio value rose 8.9% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.